Archive for category: Materials

ARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic Targeting

ARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic Targeting

/ November 27, 2017 9:51 am

ARCA Plans Genetically-Targeted Development of a New Chemical Entity (AB171) for Peripheral Arterial Disease and Heart Failure RCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced the European […]

Pluristem Expands its Reach in the Treatment of Impaired Hematopoietic Systems with a European Patent Covering PLX-R18 in Chemotherapy, ARS, Genetic Disorders and Autoimmune Diseases

Pluristem Expands its Reach in the Treatment of Impaired Hematopoietic Systems with a European Patent Covering PLX-R18 in Chemotherapy, ARS, Genetic Disorders and Autoimmune Diseases

/ October 27, 2017 8:08 am

Pluristem Therapeutics Inc. (NASDAQ: PSTI, TASE: PSTI), a leading developer of placenta-based cell therapy products, announced today that the European Patent Office has issued the company a patent titled, “Methods for Treating Radiation or Chemical Injury” for its PLX-R18 cell […]

ASIT biotech announces the grant of a European patent on the active ingredients used in the ASIT+™ allergy immunotherapy product candidates

ASIT biotech announces the grant of a European patent on the active ingredients used in the ASIT+™ allergy immunotherapy product candidates

/ October 19, 2017 9:00 am

Brussels, Belgium, October 17, 2017, 6:30 pm (CEST) – ASIT biotech (Euronext: ASIT – BE0974289218), a Belgian clinical-stage biopharmaceutical company focused on the research, development and future commercialization of breakthrough immunotherapy products for the treatment of allergies, announces the positive […]

European Patent Office Grants DeviceAtlas Patent for Core Device Detection Algorithm

European Patent Office Grants DeviceAtlas Patent for Core Device Detection Algorithm

/ September 26, 2017 1:12 pm

COLOGNE, Germany and DUBLIN, Sept. 14, 2017 /PRNewswire/ — Afilias Technologies today announced at DMEXCO that it has been granted a third patent related to its device detection algorithm used in its DeviceAtlas product. DeviceAtlas is widely adopted by major companies in the web […]

New Patents Granted to Sabinsa’s Cosmetics Division in US And EU

New Patents Granted to Sabinsa’s Cosmetics Division in US And EU

/ September 26, 2017 12:49 pm

Sabinsa Cosmetics, a division of the Sami Labs – Sabinsa Group, has been granted two new patents on novel cosmetic compositions, both developed from extensive research on combinations of the companies branded ingredients. These most recent patents are likely to […]

Cantargia obtains patent approval in Europe for the antibody CAN04 in development for treatment of cancer

Cantargia obtains patent approval in Europe for the antibody CAN04 in development for treatment of cancer

/ September 14, 2017 10:00 am

Cantargia AB (”Cantargia”) today announced that the European Patent Office (“EPO”) has granted the company’s patent application on the product candidate CAN04. CAN04 is targeted against the molecule IL1RAP expressed in a large number of cancer diseases. The formal approval […]

SPX Steel Panel System Receives Patent Grant In USA and Europe

SPX Steel Panel System Receives Patent Grant In USA and Europe

/ September 14, 2017 9:51 am

SPX Structures is pleased to announce the United States and European Patent offices have each granted patents on the SPX structural steel wall and floor panel system for commercial and residential construction. In addition to new custom commercial and residential […]

RegeneRx Collaborators Receive Notice of ‘Intent to Grant’ EU Patent for the Treatment of Peripheral Neuropathy

RegeneRx Collaborators Receive Notice of ‘Intent to Grant’ EU Patent for the Treatment of Peripheral Neuropathy

/ August 22, 2017 8:32 am

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the European Patent Office (EPO) has issued an Intent to Grant notice related to Thymosin beta 4 […]

Suven Life secures Process Patents in Europe, Japan and New Zealand

Suven Life secures Process Patents in Europe, Japan and New Zealand

/ August 17, 2017 8:16 am

Suven Life Sciences Ltd (Suven) announces today that the grant of of one (1) process patent from Europe (3077375), one (1) process patent from Japan (6151453) and one (1) process patent from New Zealand (719671) corresponding to the New Chemical Entities (NCEs) which […]

European Patent Office to Grant Merck’s Patent Application for CRISPR Technology

European Patent Office to Grant Merck’s Patent Application for CRISPR Technology

/ August 10, 2017 9:50 am

Patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Related patent application recently awarded in Australia; similar patents pending in other countries, favourable outcomes anticipated Darmstadt, Germany, August 3, 2017 — Merck, a leading […]